Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Discover what are legal ways to make money fast and find opportunities that align with your skills. Start your journey to earnings today.
16,574 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
A private AI company is offering under-$1 pre-IPO shares to everyday investors as it targets a Nasdaq debut later thi...
Apple faces a window of opportunity as upbeat quarterly results and expanding services/supporting growth drivers push...
When a founder-led brand hits a leadership cliff, markets react fast. This article explains why holding's stock crash...
A major broker cuts Alibaba's target to $170 after a sharp drop in Q3 profits, driven by heavy AI investment. The clo...
The head of OURA says the CEO role is far tougher than imagined, revealing the psychological weight, team dynamics, a...
With gas prices hovering near $4 per gallon, diners are tightening belts, and restaurant sales are cooling. Analysts ...
A little-known international ETF is quietly outperforming the S&P 500 this year, riding a multi-factor strategy and l...
Bitcoin tops $80,000 again as Canaccord Genuity raises MicroStrategy’s price target to $224, highlighting a move towa...
As Republic Services reveals Q1 2026 figures, investors gain a window into revenue growth, margins, and cash flow. Th...
Could Amazon pull ahead of the broader market? This article builds a disciplined case for why Amazon might outperform...
A prominent real estate fund made a bold $5 million move on InvenTrust Properties as the stock trailed the S&P 500. T...